Results 11 to 20 of about 44,465 (273)

Safety of Perioperative Aprotinin Administration During Isolated Coronary Artery Bypass Graft Surgery: Insights From the ART (Arterial Revascularization Trial) [PDF]

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
BackgroundThere is still uncertainty about the safety of aprotinin for coronary artery bypass graft surgery. The ART (Arterial Revascularization Trial) was designed to compare survival after bilateral versus single internal thoracic artery grafting. Many
Umberto Benedetto   +7 more
doaj   +10 more sources

Aprotinin may increase mortality in low and intermediate risk but not in high risk cardiac surgical patients compared to tranexamic acid and ε-aminocaproic acid -- a meta-analysis of randomised and observational trials of over 30.000 patients. [PDF]

open access: yesPLoS ONE, 2013
BackgroundTo compare the effect of aprotinin with the effect of lysine analogues (tranexamic acid and ε-aminocaproic acid) on early mortality in three subgroups of patients: low, intermediate and high risk of cardiac surgery.Methods and findingsWe ...
Patrick Meybohm   +3 more
doaj   +5 more sources

Inhibitory effects of aprotinin on influenza A and B viruses in vitro and in vivo

open access: yesScientific Reports, 2021
Influenza viruses cause significant morbidity and mortality worldwide. Long-term or frequent use of approved anti-influenza agents has resulted in drug-resistant strains, thereby necessitating the discovery of new drugs. In this study, we found aprotinin,
Eun-Jung Song   +8 more
doaj   +2 more sources

Aprotinin Inhibits SARS-CoV-2 Replication

open access: yesCells, 2020
Severe acute respiratory syndrome virus 2 (SARS-CoV-2) is the cause of the current coronavirus disease 19 (COVID-19) pandemic. Protease inhibitors are under consideration as virus entry inhibitors that prevent the cleavage of the coronavirus spike (S ...
Denisa Bojkova   +13 more
doaj   +2 more sources

Aprotinin: is it time to reconsider?

open access: yesEuropean Journal of Anaesthesiology, 2015
SCOPUS: re.j ; info:eu-repo/semantics ...
S. Hert   +10 more
semanticscholar   +6 more sources

Aprotinin in orthotopic liver transplantation [PDF]

open access: yesSeminars in Thrombosis and Hemostasis, 1993
Aprotinin is a protease inhibitor isolated from bovine lungs and othcr lissues. Its biochcmical struc!Urc, a single-chain polypeptide of 6.5 12 kD , and biophysical properties are weH defined. I The activity of commcrcial preparations of apralini n is usually describcd in kallikrein inac ti valor unils (KIU) , 0. 1 million KIU being equivalent 102.
Bechstein, W. O.   +8 more
core   +4 more sources

Binding of sodium dodecyl sulfate to aprotinin and its effect on the aprotinin molecule.

open access: bronzeChemical and Pharmaceutical Bulletin, 1986
When the basic protease inhibitor aprotinin was treated with sodium dodecyl sulfate (SDS), it showed an increased apparent molecular weight upon SDS gel electrophoresis. The amount of SDS bound to aprotinin was much lower than that bound to aprotinin treated with SDS and mercaptoethanol (ME).
Tadahiro Shikimi
openalex   +5 more sources

Avaliação da aprotinina na redução da resposta inflamatória sistêmica em crianças operadas com circulação extracorpórea Assessment of aprotinin in the reduction of inflammatory systemic response in children undergoing surgery with cardiopulmonary bypass [PDF]

open access: yesBrazilian Journal of Cardiovascular Surgery, 2010
OBJETIVO: Avaliar se a aprotinina em altas doses hemostáticas pode reduzir o processo inflamatório após circulação extracorpórea (CEC) em crianças. MÉTODOS: Estudo prospectivo randomizado em crianças de 30 dias a 4 anos de idade, submetidas à correção de
Cesar Augusto Ferreira   +7 more
doaj   +4 more sources

Procoagulant Action of Aprotinin

open access: bronzeAnesthesia & Analgesia, 1996
G. J. Despotis   +3 more
  +7 more sources

Aprotinin Inhibits Thrombin Generation by Inhibition of the Intrinsic Pathway, but is not a Direct Thrombin Inhibitor

open access: yesTH Open, 2021
Background Aprotinin is a broad-acting serine protease inhibitor that has been clinically used to prevent blood loss during major surgical procedures including cardiac surgery and liver transplantation.
Ton Lisman   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy